Adjunctive Traditional Chinese Medicine Improves Survival in Patients With Advanced Lung Adenocarcinoma Treated With First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs): A Nationwide, Population-Based Cohort Study

Objectives: The clinical effect of traditional Chinese medicine (TCM) on survival in patients with advanced lung adenocarcinoma treated with first-line epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) is a major concern and requires more evidence from large-scale clinical st...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chia-Ling, Hsia, Te-Chun, Li, Chia-Hsiang, Chen, Ko-Jung, Yang, Yao-Hsu, Yang, Su-Tso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242801/
https://www.ncbi.nlm.nih.gov/pubmed/30836771
http://dx.doi.org/10.1177/1534735419827079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242801/
https://www.ncbi.nlm.nih.gov/pubmed/30836771
http://dx.doi.org/10.1177/1534735419827079

Ejemplares similares